Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Tuesday. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Price Performance

Shares of NASDAQ:RKDA opened at $4.81 on Tuesday. The company has a market capitalization of $6.54 million, a price-to-earnings ratio of -1.12 and a beta of 0.88. The business’s 50-day moving average is $5.48 and its 200-day moving average is $3.93. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences at the end of the most recent reporting period. 17.73% of the stock is currently owned by institutional investors.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.